HomeCancerProstate

Prostate

ADM Korea Proclaims Niclosamide-based Metabolic Anticancer Drug’s First Medical Trial Goal as ‘Prostate Most cancers Sufferers Proof against Hormone Remedy’

IND for medical examine for mixture remedy with hormone remedy in prostate most cancers sufferers to be submitted in August, 2024. Niclosamide-based metabolic anticancer...

Exploiting epigenetic targets to beat taxane resistance in prostate most cancers

Institution and characterization of Dtx and Cbz resistant PCa cellsDtx and Cbz resistant cell traces (DtxR and CbzR, respectively) had been generated from...

Lancet Fee predicts sharp enhance in international prostate most cancers circumstances

Instances of prostate most cancers are projected to double from 1.4...

Hot Topics